Microchip Technology reported QQ1 2025 results that reflect the cyclicality typical of the semiconductor industry. Revenue came in at $1.2413B, down -45.76% year over year and -6.37% quarter over quarter, signaling weaker end-market demand relative to the prior-year period. Despite the revenue contraction, gross margins remained strong at approximately 59.36%, and operating margin stood at about 17.65%, underscoring the company’s ability to preserve profitability in a downturn driven by volume declines and mix shifts. Net income was $129.3M with earnings per share of $0.24. The company generated solid operating cash flow of $377.1M and free cash flow of $304.2M, supporting deleveraging and shareholder return activity even as total debt remained elevated at about $6.20B and net debt around $5.89B. The balance sheet shows substantial goodwill and intangible assets, contributing to a high asset base and a leverage profile (debt to equity near 0.97; debt ratio ~0.39). Liquidity metrics remained reasonable but are sensitive to cyclicality, with a current ratio of ~1.94 and cash ratio ~0.21. Absent explicit forward guidance in the data, the outlook hinges on demand stabilization in auto/industrial segments and continued execution on cost discipline and working capital management. Management commentary (when available) typically emphasizes pipeline strength in embedded processing, R&D, and select design-wins; however, the QQ1 data indicate a revenue trough that will require favorable end-market dynamics to re-accelerate growth. Investors should monitor: (1) demand recovery signals in MCUs/analog/mixed-signal applications, (2) ongoing cost controls and inventory normalization, (3) debt reduction progress and capital allocation decisions, and (4) potential upside from licensing and product mix shifts.
Key Performance Indicators
Revenue
Decreasing
1.24B
QoQ: -6.37% | YoY: -45.76%
Gross Profit
Decreasing
736.90M
59.37% margin
QoQ: -6.71% | YoY: -52.71%
Operating Income
Decreasing
219.10M
QoQ: -13.57% | YoY: -75.74%
Net Income
Decreasing
129.30M
QoQ: -16.42% | YoY: -80.60%
EPS
Decreasing
0.24
QoQ: -17.24% | YoY: -80.33%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: $1.2413B; YoY change: -45.76%; QoQ change: -6.37%
Gross Profit: $736.9M; Gross Margin: 59.36%; YoY Gross Profit change: -52.71%; QoQ: -6.71%
Operating Income: $219.1M; Operating Margin: 17.65%; YoY OpEx change not disclosed in data; QoQ: -13.57%
Net Income: $129.3M; Net Margin: 10.42%; YoY Net Income change: -80.60%; QoQ: -16.42%
EPS (basic/diluted): $0.24; YoY EPS change: -80.33%; QoQ: -17.24%
Operating Cash Flow: $377.1M; Free Cash Flow: $304.2M; Cash at End of Period: $315.1M
Cash Flow Turn: Net cash provided by operating activities aligns with FCF; Investing activities burned cash of $125.5M; Financing activities consumed $256.2M (debt repayment $185.5M, share repurchases $72.7M, dividends $242.6M)
Balance Sheet Liquidity: Total current assets $2.9483B; Total current liabilities $1.5203B; Current ratio 1.939; Quick ratio 1.079; Cash & equivalents $315.1M; Total debt $6.2029B; Net debt $5.8878B; Equity $6.406B; Total assets $15.84B
Valuation/Leverage Indicators: Debt-to-equity ~0.97; Gross margin ~59.36%; EBITDAR ~33.06%; Net debt/EBITDA not directly provided but implied elevated leverage; P/E ~95.0x and price-to-book ~7.67x based on available ratios (varied by equity base).
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
1.24B
-45.76%
-6.37%
Gross Profit
736.90M
-52.71%
-6.71%
Operating Income
219.10M
-75.74%
-13.57%
Net Income
129.30M
-80.60%
-16.42%
EPS
0.24
-80.33%
-17.24%
Key Financial Ratios
Gross Profit Margin
Good
59.40%
Gross profit margin is healthy and competitive within industry standards
Operating Profit Margin
Good
17.70%
Operating margin is healthy and competitive within industry standards
Net Profit Margin
Good
10.40%
Net profit margin is healthy and competitive within industry standards
Return on Assets
Weak
0.82%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
2.02%
Return on equity suggests inefficient capital allocation
Current Ratio
Healthy
1.94
Current ratio shows adequate liquidity to meet short-term obligations